ScholarIQanswers from OpenAlex
Friedrich Baur Stiftung
InstitutionResearch output, impact & collaborations
Friedrich Baur Stiftung is a institution indexed in ScholarIQ from OpenAlex.
What is known about Friedrich Baur Stiftung?
ScholarIQrecord summary
Friedrich Baur Stiftung is a research organisation in Altenkunstadt, DE. OpenAlex records 1,466 works and 92,443 citations for it. 205 researchers list it as their most recent affiliation.
How many works does Friedrich Baur Stiftung have?
ScholarIQindexed works
Friedrich Baur Stiftung has 1,466 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Friedrich Baur Stiftung have?
ScholarIQcitation count
Friedrich Baur Stiftung has 92,443 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Friedrich Baur Stiftung?
ScholarIQresearcher count
Friedrich Baur Stiftung has 205 researchers in the ScholarIQ index.
What is the average h-index at Friedrich Baur Stiftung?
ScholarIQavg h-index
Friedrich Baur Stiftung has an average h-index of 76 in OpenAlex.
What is the ROR of Friedrich Baur Stiftung?
ScholarIQror
The ROR for Friedrich Baur Stiftung is on the source record.
What is the OpenAlex record for Friedrich Baur Stiftung?
ScholarIQopenalex
The OpenAlex for Friedrich Baur Stiftung is on the source record.
Who are the most-cited researchers behind Friedrich Baur Stiftung?
ScholarIQtop researchers by citations
What are the most-cited papers on Friedrich Baur Stiftung?
ScholarIQmost cited works
The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene
Klaus Gempel, Haluk Topaloğlu, Beril Talim, Peter Schneiderat, Benedikt Schoser, Volkmar Hans, Beatrix Pálmafy, Gülsev Kale, Ayşegül Tokatlı, Catarina M. Quinzii, Michio Hirano, Ali Naini, Salvatore DiMauro, Holger Prokisch, Hanns Lochmüller, Rita Horváth
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf, Shafeeq Ladha, Tahseen Mozaffar, Volker Straub, António Toscano, Ans T. van der Ploeg, Kenneth I. Berger, Paula R. Clemens, Yin‐Hsiu Chien, John W Day, С. Н. Иллариошкин, Mark Roberts, Shahram Attarian, João Borges, Francoise Bouhour, Young‐Chul Choi, Sevim Erdem‐Özdamar, Özlem Göker-Alpan, Anna Kostera‐Pruszczyk, Kristina An Haack, Christopher Hug, Olivier Huynh‐Ba, Judith Johnson, Nathan Thibault, Tianyue Zhou, Mazen M. Dimachkie, Benedikt Schoser, Anthony Béhin, Matthias Boentert, Gérson Carvalho, Nizar Chahin, Joel Charrow, Patrick Deegan, Hacer Durmuş Tekçe, Fanny Duval, Angela Genge, Ludwig Gutmann, Robert D. Henderson, Julia B. Hennermann, Tarekegn Hiwot, Derralynn Hughes, Amel Karaa, Chafic Karam, Alexandra Kautzky‐Willer, Hirofumi Komaki, Pascal Laforêt, Nicola Longo, Vĕra Malinová, Ricardo Maré, Clarisa Maxit, Eugen Mengel, Maurizio Moggio, Mária Judit Molnár, Tiziana Mongini, Aleksandra Nadaj‐Pakleza, A. Nascimento Osorio, Jean‐Baptiste Noury, Acary Souza Bullé Oliveira, Yeşim Parman, Loren Peña, Gauthier Remiche, Monica Sciacco, Perry B. Shieh, Cheryl J. Smith, Thomas M. Stulnig, Frédéric Taithe, Céline Tard, Mark A. Tarnopolsky, Matthias Vorgerd, Chester B. Whitley, Peter Young, Jorge Alonso‐Pérez, Patricia Altemus, Anne-Catherine Aubé-Nathier, Jennifer Avelar, Carrie Bailey, Can Ebru Bekircan‐Kurt, Jenny Billy, Silvia Boschi, Kathryn E. Brown, Laura Carrera‐García, Lauren Chase, Hamilton Cirne, Loïc Danjoux, Jean‐Baptiste Davion, Stephanie DeArmey, E. Yu. Fedotova, Eve Gandolfo, Zoltán Grosz, Dewi Guellec, Anne-Katrin Guettsches, Michela Guglieri, Erin Hatcher, Sina Helms, Miriam Hufgard‐Leitner, S. A. Klyushnikov, Jacqui Langton, Lenka Linková
Consensus-based care recommendations for adults with myotonic dystrophy type 1
Tetsuo Ashizawa, Cynthia Gagnon, William J. Groh, Laurie Gutmann, Nicholas E. Johnson, G. Meola, Richard T. Moxley, Shree Pandya, Mark T. Rogers, Ericka Simpson, Nathalie Angeard, Guillaume Bassez, Kiera N. Berggren, Deepak Bhakta, Marco Bozzali, Ann Broderick, Janice L. B. Byrne, Craig Campbell, Edith H. C. Cup, John W. Day, Elisa De Mattia, Denis Duboc, Tina Duong, Katy Eichinger, Anne‐Berit Ekström, Baziel G.M. van Engelen, Belen Esparis, B. Eymard, Marla B. Ferschl, Shahinaz M. Gadalla, Benjamin Gallais, Todd Goodglick, Chad Heatwole, James E. Hilbert, Venessa Holland, Marie Kierkegaard, Wilma J. Koopman, Kari R. Lane, Daphne Maas, Ami Mankodi, Katherine D. Mathews, Darren G. Monckton, David J. Moser, Saman Nazarian, Linda Nguyen, Peg Nopoulos, Richard Petty, Janel Phetteplace, Jack Puymirat, Subha V. Raman, Louis Richer, Elisabetta Roma, Jacinda B. Sampson, Valeria Sansone, Benedikt Schoser, Laurie Sterling, Jeffrey Statland, S. H. Subramony, Cuixia Tian, Careniña Trujillo, Gordon F. Tomaselli, Chris Turner, Shannon L. Venance, Aparajitha Verma, Molly White, Stefan Winblad
Polyglucosan body myopathy caused by defective ubiquitin ligase RBCK1
Johanna Nilsson, Benedikt Schoser, Pascal Laforêt, Ognian Kalev, Christopher Lindberg, Norma B. Romero, Marcela Dávila López, Hasan O. Akman, Karim Wahbi, Stephan Iglseder, Christian Eggers, Andrew G. Engel, Salvatore DiMauro, Anders Oldfors
How much of the research on Friedrich Baur Stiftung is open access?
ScholarIQopen access share
100%OPEN ACCESS